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Lewis S. Seiden, a pioneering psychopharmacologist,
dedicated mentor, and inspiring colleague died on July 26,
2007, at the age of 72 years, not far from where he was
born on August 1, 1934. Lew grew up in the South Shore
neighborhood of Chicago and, with his characteristically
infectious smile and twinkling eyes, was quite fond of
telling visitors about being a high school dropout...before
relating that he entered the University of Chicago at the age
of 16 with a full-tuition scholarship. Lew was planning on
studying medicine as an undergraduate, but was tragically
stricken with dystonia musculorum deformans shortly
before his anticipated graduation in 1950. He subsequently
resumed studies after a year of convalescence and learning
to adapt to substantial impairments in balance, movement,
and speech as the result of his illness. He earned first a B.A.
in Liberal Arts in 1956 prior to a B.S. in Biology in 1958.
Lew remained at the University of Chicago for graduate
school where he earned his Ph.D. in Biopsychology in 1962
and married Anne Maxwell Seiden, M.D.; they had three
children Alex, Evelyn, and Samuel, and one grandchild,
Alex’s son Lewis.
Lew spent his entire academic career at the University of
Chicago except for two brief but transforming experiences.
He spent 2 years bringing behavioral pharmacology to the
laboratory of future Nobel laureate Arvid Carlsson in
Göteborg, Sweden, from 1962–1963. There, he published
several papers on reserpine, L-DOPA, and the conditioned
avoidance response. Carlsson later stated, “The remarkable
thing about Lew’s stay with us was that he was able to
teach us just as much as we could teach him.” Lew was
awarded an Honorary Doctorate in medicine by the
University of Göteborg in 1999.
Lew moved back to the University of Chicago following
a second postdoctoral fellowship in Keith Killam’s labora-
tory at Stanford University from 1964–1965. He moved up
the ranks, becoming a full Professor in 1977 in the
Pharmacology and the Psychiatry departments. One of the
important, and certainly revolutionary, themes of Lew’s
work during this time was not only the measurement of
drug effects on the brain and behavior but also the
compelling observations that the environment and the state
of the brain/behavior axis itself can modulate the effects of
drugs upon the brain chemistry and behavior. This was a
theme of a textbook Lew wrote in 1977 with Linda Dykstra
entitled Psychopharmacology: A Biochemical and Behav-
ioral Approach. For anyone interested in understanding
how drugs work and how to discover new drugs, these
lessons remain fresh today.
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published 165 peer-reviewed manuscripts and 41 book
chapters. His work spanned a broad expanse from his initial
paper on the partial purification of monoamine oxidase to
operant behavior to neurotoxicity. His insightful develop-
ment and thoughtful validation of an operant screen for
antidepressant drugs and the differential-reinforcement-of-
low rate 72-s (DRL 72-s) schedule has resulted in a richer
understanding of serotonergic and noradrenergic mecha-
nisms underlying antidepressant drugs that continues to
engender predictions about novel mechanisms available for
development. Lew brought to the forefront issues of
significant public health interest in all of his research. This
is highlighted by his leadership in a multidisciplinarian
effort on the neurotoxicity of amphetamine and substituted
amphetamines. Lew provided neurochemical, neuroanatom-
ical, and behavioral evidence demonstrating neurotoxicity
of methamphetamine. He and his group extended earlier
findings on fenfluramine and alerted the scientific commu-
nity to the neurotoxicological risks associated with the
amphetamine-based designer drugs, which were becoming
increasingly popular during this time.
In addition to his role as a supportive mentor, he was also
a dedicated teacher of undergraduates, an insightful col-
league, and a firm but supportive field editor for Neurophar-
macology, Behavioral Pharmacology, and The Journal of
Pharmacology and Experimental Therapeutics. Just one
example of Lew’s view on his service to others and
humility is reflected in his volunteering frequently as a
patient for Neurology board exams. In addition to all of
these scholarly activities, he still found time over the years
to enjoying sailing Lake Michigan with family, friends, and
colleagues and work on his farm in Michigan.
Amongst his many well-deserved awards included his
selection as a Fellow in the American College of Neuro-
psychopharmacology and the American Psychological As-
sociation,member ofthePresident’sAdvisoryCommitteeon
Mental Health (1978), the board of scientific counselors for
the National Institute of Environmental Services, and the
Life Sciences Working Group for NASA. In 2002, the
University of Chicago awarded Lew its Gold Key Award in
recognition of his outstanding and loyal service to the
Biological Sciences Division and the University.
Beyond these awards, Lew will remain an inspiring
figure to us as a scientist, mentor, and friend and will
continue to engender a deep degree of respect, admiration,
and affection for his scientific vision, his endearing
friendship, and for that captivating sparkle in his eyes.
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